CDX Models
Medicilon's CDX Models provide a highly reliable and reproducible platform for evaluating anti-cancer therapies.
Tumor Model Database
Medicilon's comprehensive tumor and non-tumor model enables precise efficacy evaluation, accelerating the path from discovery to clinical application.
Tumor Models
PDX Models
Highly predictive, clinically relevant platform that preserves tumor heterogeneity, enabling more accurate evaluation of drug efficacy and personalized cancer therapy.
GEM Models
Genetically engineered mouse (GEM) models are widely used and have proved to be a powerful tool to improve drug discovery processes.
Humanized Models
Offer a clinically relevant platform to study human immune-tumor interactions, accelerating the development of effective and personalized cancer therapies.
Syngeneic Models
Syngeneic tumor models are highly effective in preclinical research for studying cancer biology, assessing therapeutic strategies, and understanding immune responses.
Orthotopic Models
Enhance cancer research by replicating tumor environments, improving drug assessment, and boosting translational accuracy.
Tumor resistance models
Resistant models are important preclinical research tools for drug resistance mechanism study and development of novel therapeutic drugs or strategies.